Arsenic, syphilis, and cancer of the prostate.
Lees RE, Steele R, Wardle D.
J Epidemiol Community Health. 1985 Sep;39(3):227-30. doi: 10.1136/jech.39.3.227.
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L, March …
Lancet. 2012 Dec 15;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0.
Doxycycline.
Cunha BA, Sibley CM, Ristuccia AM.
Ther Drug Monit. 1982;4(2):115-35. doi: 10.1097/00007691-198206000-00001.
Gonorrhea, syphilis, clinical prostatitis, and the risk of prostate cancer.
Sutcliffe S, Giovannucci E, De Marzo AM, Leitzmann MF, Willett WC, Platz EA.
Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2160-6. doi: 10.1158/1055-9965.EPI-05-0913.
Correlation of hepatitis C and prostate cancer, inverse correlation of basal cell hyperplasia or prostatitis and epidemic syphilis of unknown duration.
Krystyna A, Safi T, Briggs WM, Schwalb MD.
Int Braz J Urol. 2011 Mar-Apr;37(2):223-9; discussion 230. doi: 10.1590/s1677-55382011000200009.
Sexually transmitted infections and risk of prostate cancer: review of historical and emerging hypotheses.
Sutcliffe S.
Future Oncol. 2010 Aug;6(8):1289-311. doi: 10.2217/fon.10.95.
Fascinating Molecular and Immune Escape Mechanisms in the Treatment of STIs (Syphilis, Gonorrhea, Chlamydia, and Herpes Simplex).
Scurtu LG, Jinga V, Simionescu O.
Int J Mol Sci. 2022 Mar 24;23(7):3550. doi: 10.3390/ijms23073550.
Meta-analysis of measures of sexual activity and prostate cancer.
Dennis LK, Dawson DV.
Epidemiology. 2002 Jan;13(1):72-9. doi: 10.1097/00001648-200201000-00012.
Syphilis of the prostate: report of case and review of literature.
CROWLEY E, THOMAS E.
J Urol. 1947 Nov;58(5):367-71. doi: 10.1016/S0022-5347(17)69567-3.
Gonorrhea infection increases the risk of prostate cancer in Asian population: a nationwide population-based cohort study.
Wang YC, Chung CH, Chen JH, Chiang MH, Ti-Yin, Tsao CH, Lin FH, Chien WC, Shang ST, Chang FY.
Eur J Clin Microbiol Infect Dis. 2017 May;36(5):813-821. doi: 10.1007/s10096-016-2866-7. Epub 2016 Dec 24.
